GALT – galectin therapeutics inc. (US:NASDAQ)
Stock Stats
News
Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH [Yahoo! Finance]
Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH
Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks [Yahoo! Finance]
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting [Yahoo! Finance]
Form 8-K GALECTIN THERAPEUTICS For: Dec 20
Form ARS GALECTIN THERAPEUTICS For: Dec 31
Form DEFA14A GALECTIN THERAPEUTICS
Form DEF 14A GALECTIN THERAPEUTICS For: Jan 23
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.